1. Home
  2. KEQU vs BDTX Comparison

KEQU vs BDTX Comparison

Compare KEQU & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

HOLD

Current Price

$35.18

Market Cap

106.6M

Sector

Industrials

ML Signal

HOLD

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

HOLD

Current Price

$2.15

Market Cap

116.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
BDTX
Founded
1906
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.6M
116.8M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
KEQU
BDTX
Price
$35.18
$2.15
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$10.40
AVG Volume (30 Days)
4.9K
564.6K
Earning Date
06-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.45
EPS
1.86
0.65
Revenue
$138,558,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.15
$3.28
Revenue Growth
7.72
N/A
52 Week Low
$30.33
$1.20
52 Week High
$60.89
$4.94

Technical Indicators

Market Signals
Indicator
KEQU
BDTX
Relative Strength Index (RSI) 34.70 42.35
Support Level N/A $1.93
Resistance Level $41.84 $2.67
Average True Range (ATR) 1.36 0.13
MACD -0.75 -0.01
Stochastic Oscillator 14.74 31.69

Price Performance

Historical Comparison
KEQU
BDTX

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Share on Social Networks: